tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Dyne Therapeutics price target lowered to $23 from $25 at RBC Capital
PremiumThe FlyDyne Therapeutics price target lowered to $23 from $25 at RBC Capital
7d ago
Dyne Therapeutics: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
Premium
Ratings
Dyne Therapeutics: Promising Clinical Developments and Strategic Positioning Drive Buy Rating
7d ago
Dyne Therapeutics Advances in Neuromuscular Therapies
Premium
Company Announcements
Dyne Therapeutics Advances in Neuromuscular Therapies
8d ago
Dyne Therapeutics’ DYNE-251 Study Update: A Potential Game-Changer for Duchenne Muscular Dystrophy
PremiumCompany AnnouncementsDyne Therapeutics’ DYNE-251 Study Update: A Potential Game-Changer for Duchenne Muscular Dystrophy
26d ago
Dyne Therapeutics Announces $200M Public Offering
Premium
Company Announcements
Dyne Therapeutics Announces $200M Public Offering
1M ago
Morning Movers: Tesla dips as Musk and Trump resume feud
Premium
The Fly
Morning Movers: Tesla dips as Musk and Trump resume feud
1M ago
Dyne Therapeutics initiated with a Buy at JonesResearch
PremiumThe FlyDyne Therapeutics initiated with a Buy at JonesResearch
1M ago
Dyne Therapeutics initiated with a Market Perform at Bernstein
Premium
The Fly
Dyne Therapeutics initiated with a Market Perform at Bernstein
1M ago
Dyne Therapeutics initiated with a Market Perform at Bernstein
Premium
The Fly
Dyne Therapeutics initiated with a Market Perform at Bernstein
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100